{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:56:47Z","timestamp":1776355007388,"version":"3.51.2"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec id=\"ab-eoi260004-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Among patients who have a penicillin allergy label (a history of any reaction to penicillin in their medical records), many cataract surgeries are performed yearly. Less than 1% of these patients have a true allergy to penicillin. The evidence supports limited concern regarding cephalosporin cross-reactivity; however, the guidance for surgeons regarding antibiotic selection in these patients remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260004-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine rates of perioperative antibiotic selection after penicillin allergy label reclassification vs before reclassification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260004-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Quality improvement study including 1905 patients identified with a penicillin allergy label undergoing cataract surgery between May 30, 2020, and May 30, 2025, at a large tertiary eye care center in the US. This analysis was conducted from June 2025 to December 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260004-7\">\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Policy intervention for surgeons performing cataract surgery that featured enhanced pharmacy collaboration and guidance, suppression of automated electronic medical record alerts for cephalosporin cross-reactivity, and reclassification of the allergy in the medical record. The policy intervention date was set as November 30, 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260004-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Patient receipt of intracameral antibiotics (1.0 mg\/0.1 mL of cefuroxime or 0.5 mg\/0.1 mL of moxifloxacin), topical antibiotics (eg, erythromycin or moxifloxacin), or no prophylaxis. Perioperative antibiotic selection rates were measured for all patients undergoing cataract surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260004-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 1905 patients with a penicillin allergy label in their medical record, 3077 cataract surgeries (some patients underwent &amp;amp;gt;1 cataract surgery) were performed by 51 surgeons. In an unadjusted time series analysis, the mean rate of cefuroxime use was 80.0% (95% CI, 74.5%-84.7%) after the policy intervention date, which was far above the expected use rate of 3.3% (95% CI, 2.0%-4.4%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.001). After adjustment, the mean rate of cefuroxime use was 71% (95% CI, 62%-79%) after the policy intervention date compared with a mean rate of 2% (95% CI, 1%-3%) before the intervention. The adjusted odds ratio was 0.37 (95% CI, 0.27-0.52;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) for cefuroxime use after the policy intervention date in patients with high-risk allergies (such as a history of anaphylaxis or angioedema) noted in the medical record and prior to review by a pharmacist.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260004-10\">\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>Evidence-based antibiotic selection policies for patients with a penicillin allergy label may enhance appropriate use of intracameral cefuroxime in cataract surgery. The rapid increase in cefuroxime use after the policy intervention date suggests surgeons may benefit from education and pharmacy support.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.0040","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:30:33Z","timestamp":1772728233000},"page":"325","source":"Crossref","is-referenced-by-count":1,"title":["Intracameral Cefuroxime Use in Cataract Surgery After Penicillin Allergy Reclassification"],"prefix":"10.1001","volume":"144","author":[{"given":"Karthik","family":"Reddy","sequence":"first","affiliation":[{"name":"University of Michigan Medical School, Ann Arbor"},{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Workman","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor"},{"name":"Department of Pharmacy, University of Michigan Kellogg Eye Center, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Eschenauer","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Michigan Kellogg Eye Center, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Bixler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad I.","family":"Mian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"eoi260004r1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2500\/aap.2014.35.3791","article-title":"Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population.","volume":"35","author":"Albin","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"19","key":"eoi260004r2","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.285.19.2498","article-title":"The rational clinical examination: is this patient allergic to penicillin? an evidence-based analysis of the likelihood of penicillin allergy.","volume":"285","author":"Salkind","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"eoi260004r3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.anai.2023.12.028","article-title":"A novel 2-step process for the management of inpatient beta-lactam allergy labels.","volume":"132","author":"Ravikumar","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"eoi260004r4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2497","article-title":"Antibiotic allergy in pediatrics.","volume":"141","author":"Norton","year":"2018","journal-title":"Pediatrics"},{"issue":"24","key":"eoi260004r5","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMra1807761","article-title":"Penicillin allergy.","volume":"381","author":"Castells","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"eoi260004r6","doi-asserted-by":"publisher","first-page":"354,e11","DOI":"10.1016\/j.amjmed.2005.10.052","article-title":"Is there cross-reactivity between penicillins and cephalosporins?","volume":"119","author":"Apter","year":"2006","journal-title":"Am J Med"},{"issue":"3","key":"eoi260004r7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11882-016-0594-9","article-title":"Cross-reactivity among beta-lactams.","volume":"16","author":"Romano","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"eoi260004r8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/ewjm.172.5.341","article-title":"Medical myth: ten percent of patients who are allergic to penicillin will have serious reactions if exposed to cephalosporins.","volume":"172","author":"Herbert","year":"2000","journal-title":"West J Med"},{"issue":"5","key":"eoi260004r9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jemermed.2011.05.035","article-title":"The use of cephalosporins in penicillin-allergic patients: a literature review.","volume":"42","author":"Campagna","year":"2012","journal-title":"J Emerg Med"},{"issue":"4","key":"eoi260004r10","doi-asserted-by":"publisher","first-page":"e218367","DOI":"10.1001\/jamanetworkopen.2021.8367","article-title":"Association between removal of a warning against cephalosporin use in patients with penicillin allergy and antibiotic prescribing.","volume":"4","author":"Macy","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"eoi260004r11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update.","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"eoi260004r12","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1093\/ajhp\/zxad023","article-title":"Pharmacist-led improvement in perioperative antibiotic selection for patients with a penicillin allergy label.","volume":"80","author":"Stonerock","year":"2023","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"eoi260004r13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/ajhp\/zxac385","article-title":"Pharmacist adjustment of preoperative antibiotic orders to the preferred preoperative antibiotic cefazolin for patients with penicillin allergy labeling.","volume":"80","author":"Lessard","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"eoi260004r14","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1093\/ajhp\/zxab218","article-title":"Optimizing preoperative antibiotics in patients with \u00df-lactam allergies: a role for pharmacy.","volume":"78","author":"Kwiatkowski","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"eoi260004r15","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"eoi260004r16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jcrs.2019.02.006","article-title":"Cost-utility analysis of cataract surgery in the United States for the year 2018.","volume":"45","author":"Brown","year":"2019","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"eoi260004r17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study.","volume":"32","author":"Barry","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"eoi260004r19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.survophthal.2017.04.004","article-title":"Antibiotic prophylaxis in cataract surgery in the setting of penicillin allergy: a decision-making algorithm.","volume":"62","author":"LaHood","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"eoi260004r20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jcrs.2009.01.004","article-title":"United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS endophthalmitis study.","volume":"35","author":"Gore","year":"2009","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"eoi260004r21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1442-9071.2010.02279.x","article-title":"Perioperative antibiotic prophylaxis during phaco-emulsification and intraocular lens implantation: national survey of smaller eye units in England.","volume":"38","author":"Nanavaty","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"eoi260004r22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jcrs.2018.10.044","article-title":"Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: randomized controlled clinical trial.","volume":"45","author":"Melega","year":"2019","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"eoi260004r23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ophtha.2021.10.006","article-title":"Cataract in the adult eye preferred practice pattern.","volume":"129","author":"Miller","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi260004r24","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ophtha.2017.01.026","article-title":"Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600?000 surgeries.","volume":"124","author":"Haripriya","year":"2017","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi260004r26","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S0886-3350(01)01270-6","article-title":"Prophylactic intracameral cefuroxime: evaluation of safety and kinetics in cataract surgery.","volume":"28","author":"Montan","year":"2002","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"eoi260004r27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery.","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"eoi260004r28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.2379","article-title":"Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection.","volume":"131","author":"Yin","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"eoi260004r29","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi260004r30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants.","volume":"333","author":"World Medical Association","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"eoi260004r31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.anai.2023.12.028","article-title":"A novel 2-step process for the management of inpatient beta-lactam allergy labels.","volume":"132","author":"Ravikumar","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"eoi260004r32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1214\/14-AOAS788","article-title":"Inferring causal impact using Bayesian structural time-series models.","volume":"9","author":"Brodersen","year":"2015","journal-title":"Ann Appl Stat"},{"issue":"8","key":"eoi260004r33","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jamaophthalmol.2024.1716","article-title":"Prophylactic intracameral antibiotics and endophthalmitis after cataract surgery.","volume":"142","author":"van Rooij","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi260004r34","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.","volume":"33","author":"ESCRS Endophthalmitis Study Group","year":"2007","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"eoi260004r35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrs.2013.11.002","article-title":"Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study.","volume":"40","author":"Barry","year":"2014","journal-title":"J Cataract Refract Surg"},{"issue":"24","key":"eoi260004r36","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2106\/JBJS.21.00027","article-title":"A simple algorithmic approach allows the safe use of cephalosporin in \u201cpenicillin-allergic\u201d patients without the need for allergy testing.","volume":"103","author":"Goh","year":"2021","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"eoi260004r37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaip.2017.07.033","article-title":"Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?","volume":"6","author":"Macy","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"eoi260004r38","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.jaip.2022.05.032","article-title":"Retrospective stratification of cephalosporin allergy label risk using validated penicillin allergy frameworks.","volume":"10","author":"Koo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"eoi260004r39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/antibiotics9050209","article-title":"Cephalosporins\u2019 cross-reactivity and the high degree of required knowledge: case report and review of the literature.","volume":"9","author":"D\u2019Errico","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"8","key":"eoi260004r40","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.jaip.2019.05.038","article-title":"Cross-reactivity to cephalosporins and carbapenems in penicillin-allergic patients: two systematic reviews and meta-analyses.","volume":"7","author":"Picard","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"eoi260004r41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1128\/AAC.9.3.511","article-title":"Cefuroxime, a new cephalosporin antibiotic: activity in vitro.","volume":"9","author":"O\u2019Callaghan","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"eoi260004r42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jac\/43.suppl_2.43","article-title":"Bactericidal properties of moxifloxacin and post-antibiotic effect.","volume":"43","author":"Boswell","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"eoi260004r43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcrs.2016.10.024","article-title":"Effect of the administration period of perioperative topical levofloxacin on normal conjunctival bacterial flora.","volume":"43","author":"Nejima","year":"2017","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"eoi260004r44","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.ophtha.2011.03.017","article-title":"Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: a controlled, longitudinal study.","volume":"118","author":"Dave","year":"2011","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi260004r45","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ophtha.2009.02.024","article-title":"A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.","volume":"116","author":"Moss","year":"2009","journal-title":"Ophthalmology"},{"key":"eoi260004r46","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-025-06877-8","article-title":"Leveraging retrieval\u2014augmented large language models for patient education in ophthalmology.","author":"Reddy","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"eoi260004r47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13223-023-00842-y","article-title":"Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.","volume":"19","author":"Alagoz","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"9","key":"eoi260004r48","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jcrs.2013.06.008","article-title":"Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery.","volume":"39","author":"Moisseiev","year":"2013","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"eoi260004r49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.18176\/jiaci.0741","article-title":"Anaphylactic shock following cataract surgery: a documented intracameral cefuroxime allergy.","volume":"32","author":"Mahiat","year":"2022","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"eoi260004r50","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ophtha.2009.03.014","article-title":"Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.","volume":"116","author":"Sharifi","year":"2009","journal-title":"Ophthalmology"},{"key":"eoi260004r25","volume-title":"Cefuroxime","author":"Omole","year":"2024"},{"key":"eoi260004r18","unstructured":"European Society of Cataract and Refractive Surgeons. European Society of Cataract and Refractive Surgeons (ESCRS) guideline for cataract surgery. Accessed February 3, 2026. https:\/\/www.escrs.org\/escrs-guideline-for-cataract-surgery\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2845979\/jamaophthalmology_reddy_2026_oi_260004_1776173505.52785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:00:25Z","timestamp":1776351625000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2845979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.0040","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}